Medpace Holdings, Inc.
MEDP
$428.03
$11.992.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.03% | 23.74% | 14.24% | 9.30% | 7.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.03% | 23.74% | 14.24% | 9.30% | 7.66% |
| Cost of Revenue | 8.73% | 8.62% | 8.33% | 3.69% | 1.97% |
| Gross Profit | 42.60% | 30.90% | 17.09% | 12.13% | 10.46% |
| SG&A Expenses | -1.14% | -2.31% | 12.57% | 31.34% | 6.87% |
| Depreciation & Amortization | -5.00% | -6.24% | -3.05% | -0.89% | 7.66% |
| Other Operating Expenses | 68.27% | 43.50% | 17.14% | 9.76% | -3.32% |
| Total Operating Expenses | 35.01% | 23.05% | 12.77% | 9.35% | 0.03% |
| Operating Income | 22.25% | 26.31% | 20.15% | 9.08% | 43.58% |
| Income Before Tax | 17.14% | 20.26% | 12.72% | 4.78% | 47.60% |
| Income Tax Expenses | 28.68% | 41.84% | 54.89% | -64.92% | 35.90% |
| Earnings from Continuing Operations | 15.48% | 15.25% | 2.16% | 11.70% | 49.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.48% | 15.25% | 2.16% | 11.70% | 49.45% |
| EBIT | 22.25% | 26.31% | 20.15% | 9.08% | 43.58% |
| EBITDA | 20.71% | 24.26% | 18.65% | 8.46% | 40.93% |
| EPS Basic | 26.41% | 27.18% | 10.69% | 13.43% | 48.35% |
| Normalized Basic EPS | 28.13% | 32.70% | 22.14% | 6.35% | 46.52% |
| EPS Diluted | 26.94% | 28.24% | 12.73% | 14.69% | 49.22% |
| Normalized Diluted EPS | 28.91% | 33.91% | 24.10% | 7.48% | 47.37% |
| Average Basic Shares Outstanding | -8.58% | -9.38% | -7.71% | -1.48% | 0.74% |
| Average Diluted Shares Outstanding | -9.13% | -10.19% | -9.17% | -2.52% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |